NPs Basic Information

Name
3-Ethyl-2-nonanone
Molecular Formula C11H22O
IUPAC Name*
3-ethylnonan-2-one
SMILES
CCCCCCC(CC)C(=O)C
InChI
InChI=1S/C11H22O/c1-4-6-7-8-9-11(5-2)10(3)12/h11H,4-9H2,1-3H3
InChIKey
MDEKWAMTZCERKO-UHFFFAOYSA-N
Synonyms
3-Ethyl-2-nonanone; SCHEMBL2495651; AKOS010226771
CAS NA
PubChem CID 23288860
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic oxygen compounds
      • Class: Organooxygen compounds
        • Subclass: Carbonyl compounds
          • Direct Parent: Ketones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 170.29 ALogp: 3.9
HBD: 0 HBA: 1
Rotatable Bonds: 7 Lipinski's rule of five: Accepted
Polar Surface Area: 17.1 Aromatic Rings: 0
Heavy Atoms: 12 QED Weighted: 0.521

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.345 MDCK Permeability: 0.00001500
Pgp-inhibitor: 0.002 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.919
30% Bioavailability (F30%): 0.963

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.964 Plasma Protein Binding (PPB): 94.98%
Volume Distribution (VD): 1.295 Fu: 3.45%

ADMET: Metabolism

CYP1A2-inhibitor: 0.821 CYP1A2-substrate: 0.927
CYP2C19-inhibitor: 0.46 CYP2C19-substrate: 0.776
CYP2C9-inhibitor: 0.395 CYP2C9-substrate: 0.896
CYP2D6-inhibitor: 0.02 CYP2D6-substrate: 0.551
CYP3A4-inhibitor: 0.132 CYP3A4-substrate: 0.214

ADMET: Excretion

Clearance (CL): 11.204 Half-life (T1/2): 0.721

ADMET: Toxicity

hERG Blockers: 0.043 Human Hepatotoxicity (H-HT): 0.081
Drug-inuced Liver Injury (DILI): 0.127 AMES Toxicity: 0.008
Rat Oral Acute Toxicity: 0.051 Maximum Recommended Daily Dose: 0.024
Skin Sensitization: 0.551 Carcinogencity: 0.094
Eye Corrosion: 0.987 Eye Irritation: 0.985
Respiratory Toxicity: 0.923
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000554 0.595 D0Y3KG 0.349
ENC000797 0.550 D0AY9Q 0.321
ENC000306 0.526 D01QLH 0.286
ENC000833 0.525 D0FD0H 0.273
ENC000570 0.523 D03LGY 0.269
ENC000254 0.514 D0ZK8H 0.268
ENC000454 0.513 D0I4DQ 0.263
ENC000459 0.513 D05ATI 0.254
ENC000519 0.512 D0G2KD 0.253
ENC001126 0.512 D02MLW 0.253
*Note: the compound similarity was calculated by RDKIT.